Search research articles
Contact Us
Filters
Showing results (11-20 of 142) with videos related to
Page
of 15
Sort By:
Journal of Cell Science. Supplement
|
January 1, 1984
A structural analysis of the role of the nuclear matrix and DNA loops in the organization of the nucleus and chromosome
K J Pienta, D S Coffey
The Urologic Clinics of North America
|
May 1, 1997
The use of prostate-specific antigen as a surrogate end point in the treatment of patients with hormone refractory prostate cancer
D C Smith, K J Pienta
Seminars in Oncology
|
April 6, 1999
Paclitaxel in the treatment of hormone-refractory prostate cancer
D C Smith, K J Pienta
Urology
|
June 15, 1999
A unifying model to explain the increased incidence and higher mortality of prostate cancer in black men
J E Montie, K J Pienta
Seminars in Oncology
|
December 22, 1999
Novel molecular targets for prostate cancer therapy
J M Kamradt, K J Pienta
Biotechniques
|
February 23, 2000
Modified differential display technique that eliminates radioactivity and decreases screening time
K J Pienta, E D Schwab
Expert Opinion on Pharmacotherapy
|
March 16, 2001
Etoposide in prostate cancer
J M Kamradt, K J Pienta
Medical Hypotheses
|
February 1, 1997
Modeling signal transduction in normal and cancer cells using complex adaptive systems
E D Schwab, K J Pienta
Journal of Cellular Biochemistry
|
August 1, 1992
Nuclear-cytoskeletal interactions: evidence for physical connections between the nucleus and cell periphery and their alteration by transformation
K J Pienta, D S Coffey
Current Urology Reports
|
June 27, 2002
Recent advances in chemotherapy for advanced prostate cancer
K B Olson, K J Pienta
Page
of 15
Search research articles
Search
Showing results (11-20 of 142) with videos related to
Sort By:
Page
of 15
Journal of Cell Science. Supplement
|
January 1, 1984
A structural analysis of the role of the nuclear matrix and DNA loops in the organization of the nucleus and chromosome
K J Pienta, D S Coffey
The Urologic Clinics of North America
|
May 1, 1997
The use of prostate-specific antigen as a surrogate end point in the treatment of patients with hormone refractory prostate cancer
D C Smith, K J Pienta
Seminars in Oncology
|
April 6, 1999
Paclitaxel in the treatment of hormone-refractory prostate cancer
D C Smith, K J Pienta
Urology
|
June 15, 1999
A unifying model to explain the increased incidence and higher mortality of prostate cancer in black men
J E Montie, K J Pienta
Seminars in Oncology
|
December 22, 1999
Novel molecular targets for prostate cancer therapy
J M Kamradt, K J Pienta
Biotechniques
|
February 23, 2000
Modified differential display technique that eliminates radioactivity and decreases screening time
K J Pienta, E D Schwab
Expert Opinion on Pharmacotherapy
|
March 16, 2001
Etoposide in prostate cancer
J M Kamradt, K J Pienta
Medical Hypotheses
|
February 1, 1997
Modeling signal transduction in normal and cancer cells using complex adaptive systems
E D Schwab, K J Pienta
Journal of Cellular Biochemistry
|
August 1, 1992
Nuclear-cytoskeletal interactions: evidence for physical connections between the nucleus and cell periphery and their alteration by transformation
K J Pienta, D S Coffey
Current Urology Reports
|
June 27, 2002
Recent advances in chemotherapy for advanced prostate cancer
K B Olson, K J Pienta
Page
of 15